Remembering the Past
Release time:
2020-08-14
Memories of Past
■ Qiubin Pharmaceutical Factory Wang Haibin
Sun and Moon are like flies. It has been more than 10 20 years since it entered the peak. It was in the late 1990 s. With the deepening of reform and opening up and the restructuring of state-owned enterprises, many employees of state-owned enterprises, including me, were faced with life choices. At that time, there were many employment plans to choose from. I chose Jianfeng Group, because Jianfeng was the only listed company at the same level in Jinhua City at that time, and many young people dreamed of entering. Shortly after my resume was submitted, I successfully received the notice to go to work. At that time, I was very excited and felt that I had a platform to struggle and rely on.
Shortly after I went to work at the peak, I was assigned to the preparatory group of the Pharmaceutical Development Company to engage in the "Special New" disinfectant project transferred from Tianjin Medical Institute. In those years, due to the macro-control of national infrastructure projects and the depression of the cement industry, the group company made a strategic plan to enter the pharmaceutical industry. "Special New" was the first project of Jianfeng Pharmaceutical Development Company, and its significance can be imagined. We are all very excited to be the first batch of workers in the peak medical project, and we also feel the great burden and responsibility on our shoulders.
At that time, the personnel of the project team were basically transferred from outside, including Huang Fu Xiaosheng, a government cadre from Lanxi City, Zheng Yinghua, a process engineer, Wang Yulin, an equipment engineer, Huang Chaoyun and Yang Xiaojuan, chief engineers of the original dyeing and chemical plant, and Li Chengxiang, who graduated from Peking University. These new peak people from all over the world have a common wish, hoping that through the team and their own efforts, the project will be put into effect as soon as possible and contribute to the diversified development of the peak. Some of these former colleagues have retired, some have left the peak, and the memory of them has gradually blurred over time, but the past of those who worked together is still fresh in my mind. During the period of
, the colleagues of the project team worked hard according to the division of labor, day and night. Like everyone else, I do everything well. After careful study and calculation of the pilot scheme and design drawings submitted by Tianjin Medical Institute, according to the accumulation of previous work, the process flow chart with control points and the layout of equipment level and elevation are re-optimized and designed. The process equipment is arranged three-dimensionally according to the reaction steps and operation units. The plant space is reasonably utilized, and the equipment operation, maintenance and production control are more convenient and reliable.
The work during the trial production period is even more complicated. In addition to debugging the machine, we also need to organize raw and auxiliary materials, formulate process regulations, carry out staff training, prepare the trial production plan, etc. Everyone is very busy. The most worrying thing is that the project involves many flammable, explosive, toxic and hazardous chemicals such as toluene, chlorobenzene, n-hexane, ethanol, acetic acid, etc. At that time, the hydrogenation reduction and diazotization reactions in the production process have now been The national safety supervision department determines that it is a dangerous production process, and the requirements for fire and explosion prevention are particularly high. Most of our operators are transferred from cement plants and lack understanding of chemical production. Although they have conducted strict training and assessment before, they have no perceptual knowledge of hazardous chemicals, and they are often careless and random in their work. As a result, several small safety production accidents and attempted accidents occurred. In view of these situations, we have strengthened post inspection and hidden danger investigation, strengthened safety education, training and assessment, especially through strict implementation of hot work, inspection and maintenance and other work permit systems, and strengthened the inspection and assessment of "three violations" to prevent the occurrence of more accidents. Looking back on those days, it was precisely because we practiced the peak spirit of "unity and struggle, truth-seeking and innovation, determination to rise to the top, and forever climbing the peak" that we could complete the project design, equipment installation and trial production in less than half a year.
Although "Texin" was discontinued later due to market changes and improved management requirements, the pace of development of our peak pharmaceutical industry has not stopped. The product "Shu Jiaqing" of the Jiangnan Factory of Dier Pharmaceutical, a joint venture with Dier Pharmaceutical, is sold well in the north and south of the Yangtze River. The merger of Jinhua Biochemical Pharmaceutical Factory and the registration of Zhejiang Jianfeng Pharmaceutical Co., Ltd. have entered a healthy development track since then. With the cephalosporin powder injection preparation workshop, solid preparation workshop and Qiubin Pharmaceutical Factory of Jiangnan Factory of Jianfeng Pharmaceutical Co., Ltd. successively completed and put into operation, new products such as azithromycin, gatifloxacin, Lester, paroxetine and cefmenoxime were successively introduced, and Jinxi Factory, which is in line with international counterparts, was built in 2014 . The enterprise is growing day by day, the technology and equipment are becoming more and more advanced, and the efficiency is getting better and better. As a participant who has witnessed the development of Jianfeng Pharmaceutical from scratch, from small to large, and from weak to strong, I have witnessed the leaders and colleagues who have worked hard for this all the way, and also shared the achievements and joy brought by the development of the enterprise. I deeply realize that only when the enterprise develops can we realize our ideals; only when the employees of the enterprise work hard can the enterprise develop. The individual is a seed, the enterprise is the fertile land, the seed only buried in the fertile land, it is possible to thrive.
Past is like smoke, years are like songs. On the 33rd anniversary of peak start-up 60#, recalling these past events, I am deeply gratified that I decided to come to peak, and proud that I am a peak person! Dripping water en Yongquan newspaper, a mi en thousand dou also. Thanks to the peak for giving us such a platform for development, and thanks to the peak leadership team that led us all the way forward. As an old employee, I will try my best to stand on the last shift. I hope that the young scientific and technological workers of the peak will cherish the development platform provided by the enterprise, motivate themselves with the spirit of the peak, continue to innovate, and strive to create a beautiful century-old peak!
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31